Indian Journal of Nuclear Medicine

ORIGINAL ARTICLE
Year
: 2019  |  Volume : 34  |  Issue : 4  |  Page : 271--277

Diagnostic accuracy of dual-time-point fluorodeoxyglucose-positron emission tomography/computed tomography in verification local recurrence in pancreatic cancer patients


Esraa El-Kholy1, Lobna Khaled2 
1 Department of Radiation Oncology and Nuclear Medicine, National Cancer Institute, Cairo University, Cairo, Egypt
2 Department of Radiology, Al-Azhar University, Cairo, Egypt

Correspondence Address:
Dr. Esraa El-Kholy
Department of Radiation Oncology and Nuclear Medicine, National Cancer Institute, Cairo University, Cairo
Egypt

Purpose: The aim of this study was to evaluate the accuracy of dual-time point in differentiating benign from malignant local recurrent lesions in pancreatic cancer. Patients and Methods: Thirty-four patients with pancreatic cancer (22 males and 12 females, mean age: 58.3 ± 10.3) who presented with soft-tissue lesions at the operative bed. Early whole-body positron emission tomography/computed tomography (PET/CT) and delayed imaging on the abdomen were performed. The maximum standardized uptake value (SUVmax) of the initial image (SUVmax E) and the delayed image (SUVmax D) were determined. A Retention Index (RI) was also calculated. These indices were correlated with histopathology and follow-up as reference criteria. Results: No significant statistical difference in SUVmaxE was found between benign and malignant lesions, while SUVmaxD and RI of the malignant lesions (mean 8.6 ± 2.7 and 35.8 ± 18.3, respectively) were significantly higher than those of benign ones (mean 3.3 ± 1.4 and-6.2 ± 15.2, respectively) (P < 0.005). With SUVmaxD 4.9, malignancy could be predicted with the highest sensitivity (95.8%) and accuracy (94.1%) between the whole parameters. The estimated negative and positive predictive values (PPVs) were 90.0% and 95.8%, respectively. A cutoff point 16 for RI showed higher specificity and PPV (100% and 100%, respectively). Forty-seven total (11 benign and 36 malignant) lesions were identified. Increased SUVmax is noted on delayed images in most of malignant lesions, except for two that maintained stationary. Conclusion: Dual-time-point 18F fluorodeoxyglucose-PET/CT seems to be a reliable additional method to differentiate between malignant and benign postoperative local soft-tissue lesions in patients with pancreatic cancer.


How to cite this article:
El-Kholy E, Khaled L. Diagnostic accuracy of dual-time-point fluorodeoxyglucose-positron emission tomography/computed tomography in verification local recurrence in pancreatic cancer patients.Indian J Nucl Med 2019;34:271-277


How to cite this URL:
El-Kholy E, Khaled L. Diagnostic accuracy of dual-time-point fluorodeoxyglucose-positron emission tomography/computed tomography in verification local recurrence in pancreatic cancer patients. Indian J Nucl Med [serial online] 2019 [cited 2019 Oct 18 ];34:271-277
Available from: http://www.ijnm.in/article.asp?issn=0972-3919;year=2019;volume=34;issue=4;spage=271;epage=277;aulast=El-Kholy;type=0